ClinicalTrials.Veeva

Menu

Telerehabilitation for Post COVID-19 Condition (Telecovie)

U

Université de Sherbrooke

Status

Completed

Conditions

Long COVID
Chronic Fatigue Syndrome

Treatments

Other: Telerehabilitation program based on cardiorespiratory principles

Study type

Interventional

Funder types

Other

Identifiers

NCT05973136
2022-4665

Details and patient eligibility

About

Telerehabilitation is a great alternative to offering care during a global pandemic. 85% of patients with COVID-19 report persistent symptoms up to 8 months after the infection. There are no clear recommendations for post-covid rehabilitation. The aims of the study are (1) to test the logistic aspect of implanting a hybrid rehabilitation program and (2) to evaluate the acceptability and the potential impact of the program on treating patients with functional limitations and persistent fatigue symptoms. It's a pre and post-study without a control group.

Full description

Telerehabilitation is a great alternative to offering care during a global pandemic. 85% of patients with COVID-19 report persistent symptoms up to 8 months after the infection. There are no clear recommendations for post-covid rehabilitation. The aims of the study are (1) to test the logistic aspect of implanting a hybrid rehabilitation program and (2) to evaluate the acceptability and the potential impact of the program on treating patients with functional limitations and persistent fatigue symptoms. It's a pre and post-study without a control group. The intervention will be based on cardiopulmonary rehabilitation principles and will be administered for 12 weeks. Fatigue, post-exertional malaise, and functional/exercise capacities will be evaluated.

Enrollment

7 patients

Sex

All

Ages

25 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Living in the community
  • Living near Sherbrooke (<50km)
  • Having a diagnostic of COVID-19 confirmed (PCR) and post-COVID syndrome (according to the World Health Organization criteria)
  • Being aged between 25 and 65 years old
  • Having access to internet at home
  • Living with a family member/caregiver or having a telephone or a medical alert system (in case of emergency)
  • Reporting persistent fatigue symptoms according to the Fatigue Severity Scale (FSS) (score≥4/7)
  • Reporting functional limitations according to the Post-COVID-19 Functional Status scale (PCFS (score ≥2/4);
  • Being able to give free and informed consent (adequate understanding of the study protocol);
  • Agreeing to perform a pulmonary function test, an exercise stress test, and an ergospirometric exercise test (adequate understanding of steps and procedures);
  • Having a low exercise capacity and moderate-to-severe cardiovascular risk <7 metabolic equivalent of a task (MET) or ≤9 if significant reduction of self-reported exercise tolerance according to the stress test performed on a treadmill - Cornell protocol);
  • Having no other potential explanatory causes for fatigue or reduced exercise capacity according to medical evaluation

Exclusion criteria

  • Cognitive impairment: Mini-Mental State Examination (MMSE) ≤24/30
  • Inability to perform or understand study procedures
  • Medical contraindication

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

7 participants in 1 patient group

Intervention group
Experimental group
Description:
Group of participant receiving the hybrid telerehabilitation intervention
Treatment:
Other: Telerehabilitation program based on cardiorespiratory principles

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems